Analyst Ratings for Acumen Pharmaceuticals, Inc. (ABOS)
ABOS Rating Summary
ABOS Price Target Summary
- Highest: $10.00 (Stifel)
- Lowest: $4.00 (Citi)
- Average: $7.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.00 (+190.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$7.00 (+190.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/17/2025 | Lucid Capital Markets | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.10 (2.41) |
14.76% | Details |
| 6/17/2025 | Citi | Geoff Meacham | New Coverage | Buy (N/A) |
4.00 (N/A) |
1.14 (2.41) |
111.4% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
